Your browser doesn't support javascript.
loading
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean.
Salas-Hernández, Aimeé; Galleguillos, Macarena; Carrasco, Matías; López-Cortés, Andrés; Redal, María Ana; Fonseca-Mendoza, Dora; Esperón, Patricia; González-Martínez, Farith; Lares-Asseff, Ismael; Lazarowski, Alberto; Loera-Castañeda, Verónica; Remírez, Diadelis; Martínez, Matías F; Vargas, Rodrigo; Rios-Santos, Fabricio; Macho, Antonio; Cayún, Juan P; Perez, Germán R; Gutierrez, Carolina; Cerpa, Leslie C; Leiva, Tamara; Calfunao, Susan; Xajil, Lesly; Sandoval, Christopher; Suárez, Marcelo; Gonzalez, Ariana; Echeverría-Garcés, Gabriela; Sullón-Dextre, Luis; Cordero-García, Eugenia; Morales, Alexis R; Avendaño, Andrea; Sánchez, Enrique; Bastone, Laura C; Lara, Cesar; Zuluaga-Arias, Patricia; Soler, Ana María; Da Luz, Julio; Burgueño-Rodríguez, Gabriela; Vital, Marcelo; Reyes-Reyes, Elizabeth; Huaccha, Alexander; Ariza, Yeimy V; Tzul, Naomi; Rendón, Ana L; Serrano, Roberto; Acosta, Larissa; Motta-Pardo, Angelo; Beltrán-Angarita, Leonardo; Brand, Erika; Jiménez, Miguel A.
Afiliação
  • Salas-Hernández A; Department of Pharmacology, Toxicology and Pharmaco-Dependence, Faculty of Pharmacy, University of Costa Rica, San Jose, Costa Rica.
  • Galleguillos M; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Carrasco M; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • López-Cortés A; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.
  • Redal MA; Molecular Diagnostic Laboratory, Genetics Division, Faculty of Medicine, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.
  • Fonseca-Mendoza D; Universidad del Rosario, School of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Bogotá, Colombia.
  • Esperón P; Molecular Genetic Unit, School of Chemistry, Universidad de la República, General Flores, CP 1800 2124, Montevideo, Uruguay.
  • González-Martínez F; Toxicology and Public Health Research Laboratory, Department of Research, Faculty of Dentistry, University of Cartagena, Cartagena, Colombia.
  • Lares-Asseff I; Academy of Genomics and Laboratory of Pharmacogenomics and Molecular Biomedicine, Instituto Politécnico Nacional, CIIDIR-Unidad Durango, Durango, Mexico.
  • Lazarowski A; Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires- Argentina, Buenos Aires, Argentina.
  • Loera-Castañeda V; Academy of Genomics and Laboratory of Pharmacogenomics and Molecular Biomedicine, Instituto Politécnico Nacional, CIIDIR-Unidad Durango, Durango, Mexico.
  • Remírez D; National Centre for Quality Control of Drugs, La Havana, Cuba.
  • Martínez MF; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Vargas R; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.
  • Rios-Santos F; Department of Molecular Biology, Galileo University, Guatemala City, Guatemala.
  • Macho A; Department of Health. Faculty of Medicine, Federal University of Mato Grosso (UFMT), Cuibá, Brazil.
  • Cayún JP; Morphology and Applied Immunology Research Center (NuPMIA), University of Brasilia (UnB), Brasília, Brazil.
  • Perez GR; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Gutierrez C; Department of Microbiology, Faculty of Biochemical and Pharmaceutical Sciences. National University of Rosario, Rosario, Argentina.
  • Cerpa LC; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Leiva T; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Calfunao S; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Xajil L; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Sandoval C; Laboratory Pathological Anatomy, Hospital Luis Calvo Mackenna, Santiago, Chile.
  • Suárez M; Department of Research in Pharmacogenomics, Faculty of Chemical Sciences and Pharmacy, University of San Carlos de Guatemala, Guatemala, Guatemala.
  • Gonzalez A; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Echeverría-Garcés G; Clinical Laboratory Blood Biochemistry and Immunoassay Section, Hospital Clínico Félix Bulnes Cerda, Santiago, Chile.
  • Sullón-Dextre L; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.
  • Cordero-García E; Pharmacy Service, Hospital UC-Christus, Santiago, Chile.
  • Morales AR; Medical Genetics Platform, Santa Fe, Argentina.
  • Avendaño A; Facultad de Ciencias de La Salud, Universidad Internacional de Valencia, Valencia, España.
  • Sánchez E; Sociedad de Farmacología Molecular del Perú, Lima, Perú.
  • Bastone LC; Department of Pharmacology, Toxicology and Pharmaco-Dependence, Faculty of Pharmacy, University of Costa Rica, San Jose, Costa Rica.
  • Lara C; Department of Toxicology and Pharmacology, Faculty of Pharmacy and Bioanalisis, University of Los Andes, Merida, Venezuela.
  • Zuluaga-Arias P; Department of Pediatrics, Medical Genetics Unity, Faculty of Medicine, University of Los Andes, Mérida, Venezuela.
  • Soler AM; Vivian Pellas Hospital, Managua, Nicaragua.
  • Da Luz J; Laboratorio de Medicina Genómica, Gammalab, Grupo Gamma, Rosario, Argentina.
  • Burgueño-Rodríguez G; Betesda La Alternativa Natural, San José, Costa Rica.
  • Vital M; Colombian Association of Pharmacovigilance, Bogotá, Colombia.
  • Reyes-Reyes E; Laboratorio de Genética Molecular Humana, Departamento de Ciencias Biológicas, Universidad de La República, Montevideo, Uruguay.
  • Huaccha A; Laboratorio de Genética Molecular Humana, Departamento de Ciencias Biológicas, Universidad de La República, Montevideo, Uruguay.
  • Ariza YV; Laboratorio de Genética Molecular Humana, Departamento de Ciencias Biológicas, Universidad de La República, Montevideo, Uruguay.
  • Tzul N; Molecular Genetic Unit, School of Chemistry, Universidad de la República, General Flores 2124, Montevideo, Uruguay.
  • Rendón AL; Clinical Experimental Pharmacology Section, Teaching and Research Department, Institute of Oncology and Radiobiology, Havana, Cuba.
  • Serrano R; Pharmacy Service, Hospital II 1 Moyobamba, San Martín, Perú.
  • Acosta L; Pharmaceutical Chemistry Program, El Bosque University, Bogotá, Colombia.
  • Motta-Pardo A; Drug Inspectorate Unit, Ministry of Health and Wellness, Belmopan, Belize.
  • Beltrán-Angarita L; Department of Pharmaceutical Technology, National Autonomous University of Honduras, Tegucigalpa, Honduras.
  • Brand E; PhV Latam, San Salvador, El Salvador.
  • Jiménez MA; Faculty of Biology, Chemistry and Pharmacy, Galileo University, Guatemala, Guatemala.
Front Pharmacol ; 14: 1175737, 2023.
Article em En | MEDLINE | ID: mdl-37251329

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Costa Rica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Idioma: En Revista: Front Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Costa Rica